Yes, there is a serum lithium level lab test; use ICD-10 code Z51.81 for therapeutic drug monitoring.
For therapeutic drug monitoring of lithium, order a serum lithium level and use ICD-10 code Z51.81 (Encounter for therapeutic drug level monitoring). This code specifically covers laboratory testing to measure drug levels for dose adjustment and monitoring therapeutic efficacy 1.
Laboratory Testing Details
- Test name: Serum lithium level or serum lithium concentration
- Sample type: Blood draw (venous sample preferred)
- Timing: Draw 8-12 hours after the last dose when lithium concentrations are at steady-state trough levels 1
- Frequency during maintenance: At least every 2 months in stable patients; more frequently (twice weekly) during acute phase or dose adjustments 1
Therapeutic Ranges by Age
The therapeutic targets differ by patient age:
- Adults <60 years: 0.6-1.2 mEq/L (or mmol/L) for maintenance 1
- Adults 60-79 years: 0.4-0.8 mmol/L 2
- Adults ≥80 years: 0.4-0.7 mmol/L 2
- Acute mania: 1.0-1.5 mEq/L during initial treatment 1
Elderly patients are particularly prone to neurotoxicity at higher doses and often require lower therapeutic ranges 3.
Critical Safety Considerations
Lithium toxicity occurs at levels close to therapeutic doses, making regular monitoring essential 1. Toxicity typically manifests at levels ≥1.5 mmol/L, though sensitive patients may show signs at 1.0-1.5 mEq/L 1, 4. The FDA requires facilities for prompt and accurate serum lithium determinations before initiating therapy 1.
When to Monitor More Frequently
Increase monitoring frequency (beyond every 2 months) when:
- Dose changes occur 5
- Patient becomes acutely unwell 5
- Concurrent nephrotoxic medications are used (NSAIDs, ACE inhibitors, diuretics) 5, 6
- Renal function declines (monitor GFR, electrolytes, and lithium levels every 6 months minimum in CKD) 5
Additional Monitoring Requirements
Beyond lithium levels, monitor:
- Renal function: GFR and electrolytes every 6 months or more frequently with dose changes 5
- Thyroid function: TSH monitoring recommended 7
- Hydration status: Maintain adequate hydration during intercurrent illness 5
Common Pitfalls to Avoid
- Drawing levels at wrong time: Must be 8-12 hours post-dose for accurate trough levels 1
- Relying solely on lab values: Clinical assessment is essential; do not base decisions on serum levels alone 1
- Missing drug interactions: NSAIDs, ACE inhibitors, and diuretics increase lithium levels and toxicity risk 5, 6
- Inadequate monitoring in elderly: Older patients require lower therapeutic targets and closer monitoring 3, 2
- Continuing lithium during acute illness: Temporarily suspend during dehydration, bowel prep, or major surgery 5